Mesa Laboratories Inc (MLAB.OQ)
MLAB.OQ on NASDAQ Stock Exchange Global Select Market
169.00USD
20 Apr 2018
169.00USD
20 Apr 2018
Change (% chg)
$-0.42 (-0.25%)
$-0.42 (-0.25%)
Prev Close
$169.42
$169.42
Open
$169.00
$169.00
Day's High
$169.00
$169.00
Day's Low
$168.50
$168.50
Volume
4,657
4,657
Avg. Vol
6,157
6,157
52-wk High
$170.64
$170.64
52-wk Low
$122.52
$122.52
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec | 23.67 | -3.048 |
| Sep | 22.95 | 0.598 | |
| Jun | 22.67 | 0.387 | |
| FY 2017 | Mar '17 | 24.30 | 0.941 |
| Dec | 23.84 | 0.841 | |
| Sep | 24.41 | 0.616 | |
| Jun | 21.11 | 0.508 | |
| FY 2016 | Mar '16 | 24.81 | 1.237 |
| Dec | 19.91 | 0.686 | |
| Sep | 21.78 | 0.484 | |
| Jun | 18.16 | 0.743 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 1 | 23.87 | 23.87 | 23.87 | -- |
| Quarter Ending Dec-18 | 1 | 24.85 | 24.85 | 24.85 | -- |
| Year Ending Mar-18 | 2 | 94.66 | 95.00 | 94.33 | 104.05 |
| Year Ending Mar-19 | 2 | 102.04 | 105.50 | 98.59 | 111.05 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | 0.76 | 0.76 | 0.76 | 1.10 |
| Quarter Ending Dec-18 | 1 | 0.88 | 0.88 | 0.88 | 1.07 |
| Year Ending Mar-18 | 1 | 2.62 | 2.62 | 2.62 | 3.29 |
| Year Ending Mar-19 | 2 | 4.43 | 5.45 | 3.41 | 3.89 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 55.06 | 26.34 | 24.65 | |
| P/E High - Last 5 Yrs. | 42.18 | 35.42 | 42.15 | |
| P/E Low - Last 5 Yrs. | 22.44 | 15.80 | 14.03 | |
| Beta | 0.50 | 1.00 | 0.96 | |
| Price to Sales (TTM) | 6.06 | 4.27 | 53.35 | |
| Price to Book (MRQ) | 5.70 | 3.13 | 2.69 | |
| Price to Tangible Book (MRQ) | -- | 5.74 | 4.41 | |
| Price to Cash Flow (TTM) | 29.42 | 20.30 | 16.87 | |
| % Owned Institutions | 67.76 | 1.24 | 1.89 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.42 | 1.43 | 1.46 | |
| Dividend Yield - 5 Year Avg | 0.70 | 1.58 | 1.55 | |
| Dividend 5 Year Growth Rate | 5.06 | 14.19 | 6.87 | |
| Payout Ratio(TTM) | 22.08 | 35.81 | 29.42 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 7.38 | 22.41 | 35.19 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 8.68 | 7.94 | 76.37 | |
| Sales - 5 Yr. Growth Rate | 18.78 | 4.01 | 8.08 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -23.82 | 117.52 | 111.72 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -4.46 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 4.93 | 8.39 | 12.22 | |
| Capital Spending - 5 Yr. Growth Rate | 76.22 | 8.72 | 8.01 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.36 | 3.67 | 1.90 |
| Current Ratio (MRQ) | 2.26 | 4.46 | 2.29 |
| LT Debt to Equity (MRQ) | 48.82 | 15.19 | 74.58 |
| Total Debt to Equity (MRQ) | 50.06 | 21.47 | 96.71 |
| Interest Coverage (TTM) | -- | 58.57 | 62.46 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 56.60 | 36.45 | 30.51 | |
| Gross Margin - 5 Yr. Avg. | 59.80 | 36.11 | 30.03 | |
| EBITD Margin (TTM) | 25.80 | -- | -- | |
| EBITD - 5 Yr. Avg | 29.31 | 21.90 | 19.70 | |
| Operating Margin (TTM) | 16.51 | 16.77 | 14.77 | |
| Operating Margin - 5 Yr. Avg. | 21.04 | 18.01 | 14.58 | |
| Pre-Tax Margin (TTM) | 14.10 | 18.51 | 13.37 | |
| Pre-Tax Margin - 5 Yr. Avg. | 20.43 | 18.91 | 12.28 | |
| Net Profit Margin (TTM) | 11.31 | 13.75 | 9.56 | |
| Net Profit Margin - 5 Yr. Avg. | 14.16 | 12.96 | 8.64 | |
| Effective Tax Rate (TTM) | 19.81 | 26.87 | 27.39 | |
| Effective Tax Rate - 5 Yr. Avg. | 30.72 | 28.97 | 29.25 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 249,932 | 42,389,132 | 657,034,690 | |
| Net Income/Employee (TTM) | 28,268 | 7,691,476 | 54,816,329 | |
| Receivable Turnover (TTM) | 7.52 | 4.71 | 5.69 | |
| Inventory Turnover (TTM) | 3.01 | 3.66 | 74.00 | |
| Asset Turnover (TTM) | 0.58 | 0.69 | 0.65 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 6.51 | 7.61 | 5.17 | |
| Return on Assets - 5 Yr. Avg. | 8.93 | 7.20 | 4.42 | |
| Return on Investment (TTM) | 7.34 | 9.65 | 7.25 | |
| Return on Investment - 5 Yr. Avg. | 10.10 | 9.19 | 6.32 | |
| Return on Equity (TTM) | 11.42 | 11.71 | 12.43 | |
| Return on Equity - 5 Yr. Avg. | 14.27 | 11.17 | 11.13 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 10.64 | 21.11 | 18.78 |
| EPS (TTM) % | -2.14 | 5.29 | 4.93 |
| Dividend % | 0.00 | 3.34 | 5.06 |
Note: Units in Millions of US Dollars
Performance for Mesa Laboratories Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 14.18 | 10.25 | 88 | 96 |
| 13 Week | 6.63 | 1.44 | 57 | 75 |
| 26 Week | 19.37 | 10.29 | 67 | 61 |
| 52 Week | 27.86 | 8.37 | 53 | 79 |
| YTD | 24.88 | 9.67 | 53 | 66 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 72.46% |
| # of Holders: | 132 |
| Total Shares Held: | 2,741,443 |
| 3 Mo. Net Change: | -13,788 |
| # New Positions: | 0 |
| # Closed Positions: | 2 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 10 |
| # Net Buyers: | -5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.